KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Humana (HUM) Cash & Equivalents (2016 - 2025)

Humana has reported Cash & Equivalents over the past 17 years, most recently at $4.2 billion for Q4 2025.

  • Quarterly results put Cash & Equivalents at $4.2 billion for Q4 2025, up 89.1% from a year ago — trailing twelve months through Dec 2025 was $4.2 billion (up 89.1% YoY), and the annual figure for FY2025 was $4.2 billion, up 89.1%.
  • Cash & Equivalents for Q4 2025 was $4.2 billion at Humana, down from $5.4 billion in the prior quarter.
  • Over the last five years, Cash & Equivalents for HUM hit a ceiling of $16.2 billion in Q2 2023 and a floor of $2.2 billion in Q4 2024.
  • Median Cash & Equivalents over the past 5 years was $5.0 billion (2022), compared with a mean of $6.5 billion.
  • Biggest five-year swings in Cash & Equivalents: surged 215.01% in 2022 and later tumbled 66.23% in 2024.
  • Humana's Cash & Equivalents stood at $3.4 billion in 2021, then soared by 49.12% to $5.1 billion in 2022, then dropped by 7.25% to $4.7 billion in 2023, then plummeted by 52.68% to $2.2 billion in 2024, then surged by 89.1% to $4.2 billion in 2025.
  • The last three reported values for Cash & Equivalents were $4.2 billion (Q4 2025), $5.4 billion (Q3 2025), and $4.0 billion (Q2 2025) per Business Quant data.